Vitamin K for Bone Fracture

Verdict: Does not prevent bone fractures

For preventing bone fractures, vitamin K supplements do not work. The most rigorous trials and meta-analyses find no reliable reduction in fracture risk, and no regulator or major clinic endorses vitamin K for this purpose.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

The grade reflects a surrogate-versus-outcome gap. The strongest analysis, an updated meta-analysis of 36 randomized trials (PMID 31076817), reported a benefit for any clinical fracture (OR 0.72) that disappeared once low-risk-of-bias trials were isolated (OR 0.76, 95% CI 0.58-1.01, non-significant), with no effect on vertebral fractures (OR 0.96). Its authors concluded the evidence is insufficient to confirm a fracture benefit.

The apparently positive earlier meta-analyses (PMID 16801507; PMID 25516361) were driven almost entirely by Japanese trials using prescription-grade MK-4 at 45 mg/day, roughly 500 times typical dietary intake and not generalizable to over-the-counter MK-7. The 2006 review (PMID 16801507) was later flagged by a 2018 erratum for methodological concerns. The only Western trial powered for bone outcomes, the ECKO trial of 5 mg/day K1 (PMID 18922041), was null on its primary bone-density endpoints; its lower fracture count (9 vs 20) was an underpowered, hypothesis-generating secondary finding.

Regulators and clinics align with this verdict. EFSA authorizes only a 'maintenance of normal bone' claim at dietary levels, not fracture prevention, and no agency authorizes a fracture-prevention claim. Mayo Clinic, Cleveland Clinic and Harvard all describe the trial evidence as conflicting, and orthopedic and bone-health societies do not endorse vitamin K supplements for preventing fractures, pointing instead to calcium, vitamin D, exercise and approved osteoporosis drugs.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.30
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
84%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.20
L3 MechanismPlausibility
0.25
L11 AI re-checkIndependent read
0.30
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.302
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Effect of vitamin K on bone mineral density and fractures in adults: an updated SR and MA of RCTs
PMID: 31076817 2019 統合分析
Finding: Any clinical fracture OR 0.72 (95% CI 0.55-0.95); attenuates to OR 0.76 (0.58-1.01) in low-risk-of-bias subset (NS). No effect on vertebral fractures (OR 0.96, 0.83-1.11). Authors conclude evidence insufficient to confirm fracture benefit.
🟢 High quality Effect size: [object Object]
View on PubMed
Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a RCT
PMID: 18922041 2008 RCT (double-blind) n = 440
Finding: No effect on BMD at lumbar spine or hip vs placebo. Fewer clinical fractures in K1 arm (9 vs 20, p=0.04) and fewer cancers (3 vs 12, p=0.02), but trial was not powered for these endpoints; secondary findings considered hypothesis-generating.
🟢 High quality Government Effect size: [object Object]
View on PubMed
Vitamin K and the prevention of fractures: SR and MA of RCTs
PMID: 16801507 2006 統合分析
Finding: MK-4 strongly associated with fracture reduction: vertebral OR 0.40, hip OR 0.23, all nonvertebral OR 0.19. Authors note effect was concentrated in Japanese MK-4 trials at 45 mg/day; later flagged with 2018 erratum for methodological concerns in included trials.
🟠 Limited quality Effect size: [object Object]
View on PubMed
Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a MA of RCTs
PMID: 25516361 2015 統合分析 n = 6,759
Finding: K2 reduced fracture incidence in postmenopausal osteoporotic women, particularly after sensitivity analysis removing high-heterogeneity trials. Effect driven primarily by Japanese high-dose MK-4 trials; generalizability to non-Japanese populations and to lower-dose MK-7 not established.
Effect size: Fracture incidence reduced; pooled estimate not extractable to single OR/RR (effect concentrated in Japanese MK-4 45 mg/day subset)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Vitamin K1 Injection is indicated for prophylaxis and treatment of vitamin K-deficiency bleeding in neonates source↗
L4b EU EFSA
Supportive
a cause and effect relationship has been established between the dietary intake of vitamin K and normal blood coagulation ... and the maintenance of normal bone source↗
L4c UK NHS
Cautious
You should be able to get all the vitamin K you need by eating a varied and balanced diet. Any vitamin K your body does not need immediately is stored in the liver for future use, so you do not need it in your diet every day. source↗
L4d TW TFDA / 衛福部
Supportive
成年男性 120 微克/日,女性 90 微克/日(足夠攝取量 AI) source↗
L4e WHO
Supportive
vitamin K1 should be given to all newborns as a single, intramuscular dose of 0.5–1 mg source↗
L5a NIH Office of Dietary Supplements
Supportive
Vitamin K, the generic name for a family of compounds with a common chemical structure of 2-methyl-1,4-naphthoquinone, is a fat-soluble vitamin source↗
L5b Mayo Clinic
Cautious
Some studies, many conducted in Japan, found that supplementation with vitamin K1 or vitamin K2 improved bone mineral density, and few studies showed a decreased risk of bone fractures. However, some subsequent studies found that vitamin K supplementation had no effect on bone mineral density. source↗
L5c Cleveland Clinic
Cautious
Some studies indicate that a higher daily intake of vitamin K reduces the risk of bone fractures and low bone density (osteopenia). A lot of other factors can affect bone health, including a lack of calcium and vitamin D. We need more rigorous studies to establish the link before we can confidently recommend vitamin K supplements. source↗
L5d Harvard Health
Cautious
the results of clinical trials and meta-analyses have been conflicting whether vitamin K supplements reduce bone fractures. source↗
L5e Specialty Society (condition-mapped)
Not addressed
Necessary for bone formation and mineralization, Vitamin K also is important for blood clotting, and it may assist in channeling calcium directly to the bone rather than the blood vessels. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-bone-fracture-INT-vitamin-k-001 繁體中文版 →